Top Cancer Stocks in South Korea
Browse the largest South Korea companies in the world ranked by their Market Capitalization. Global Cancer Companies in South Korea market cap is $6.28B.
11 Nov 2024, 23:05 UTC
Companies: 16
🇰🇷1 |  | $245.11 | 0.31% | 3.11B | -8.49% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇰🇷2 |  | $22.39 | 0.85% | 1.07B | 18.91% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷3 |  | $31.25 | -3.62% | 890.00M | -49.76% | Underperform S&P500 YTD Benchamark | 🦾 AI | - |
🇰🇷4 |  | $1.63 | 1.42% | 225.73M | -11.00% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇰🇷5 |  | $10.68 | 3.91% | 216.00M | -38.43% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷6 |  | $4.65 | -2.23% | 192.83M | -38.60% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷7 |  | $2.10 | 2.02% | 148.29M | -53.98% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷8 |  | $5.83 | -2.66% | 109.63M | -8.34% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷9 |  | $3.29 | 6.50% | 91.90M | 0.12% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷10 |  | $4.51 | 4.57% | 61.32M | 33.11% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷11 |  | $4.15 | -0.36% | 57.53M | -53.87% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷12 |  | $5.06 | 0.00% | 39.58M | N/A | S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷13 |  | $1.13 | 2.74% | 37.60M | -43.36% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷14 |  | $0.49 | -4.15% | 25.88M | -46.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷15 |  | $1.24 | 0.56% | 21.84M | -23.47% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷16 |  | $2.18 | 22.03% | 15.91M | -14.03% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
